Mankind Pharma IPO: The Bull Case
The key elements of the bull case rest on a track record of growing brands and market share, Â accelerating growth rates, and profitability with...
595 Views
Mankind Pharma Pre-IPO - Thoughts on Valuations
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will talk about valuations.
654 Views
Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.
669 Views
Abbott India Ltd - Key Therapies Report Robust Sales Improvement
AIL reported revenue growth of 7.1% YoY in Q1FY23 (vs. our expectations of 8% YoY), outpacing the IPM* growth of 2.0% (IPM: Indian Pharma Industry,...
359 Views
Pick of the Week: Abbott India Ltd
Revenue growth of Abbott India Ltd (AIL) for FY21 has outpaced the Indian Pharma Market (IPM) growth by 100 bps majorily contributed by addition of...
326 Views